Bessemer Group’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-95,500
Closed -$2.08M 1752
2020
Q2
$2.08M Buy
95,500
+1,000
+1% +$22.9K 0.01% 467
2020
Q1
$2.19M Buy
94,500
+2,200
+2% +$63.9K 0.01% 419
2019
Q4
$3.04M Buy
92,300
+800
+0.9% +$25.6K 0.01% 453
2019
Q3
$2.91M Buy
91,500
+4,900
+6% +$143K 0.01% 413
2019
Q2
$2.23M Buy
86,600
+9,000
+12% +$229K 0.01% 502
2019
Q1
$1.97M Buy
77,600
+67,363
+658% +$2.01M 0.01% 458
2018
Q4
$348K Buy
10,237
+9,000
+728% +$293K ﹤0.01% 842
2018
Q3
$44K Buy
+1,237
New +$43.7K ﹤0.01% 1298
2018
Q2
Sell
-5,100
Closed -$172K 1822
2018
Q1
$172K Sell
5,100
-1,575
-24% -$49.8K ﹤0.01% 1027
2017
Q4
$255K Buy
+6,675
New +$266K ﹤0.01% 972
2017
Q3
Sell
-20,900
Closed -$780K 1916
2017
Q2
$780K Sell
20,900
-23,800
-53% -$860K ﹤0.01% 738
2017
Q1
$1.75M Hold
44,700
0.01% 539
2016
Q4
$1.56M Hold
44,700
0.01% 591
2016
Q3
$1.76M Buy
+44,700
New +$1.78M 0.01% 482

Other funds holding NTUS

Bessemer Group's NTUS Position: Q3 2020 in Review

Bessemer Group sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 95,500 shares — an estimated $2.08M sold.

Bessemer Group first reported a position in NTUS in Q3 2016 and held it in 14 quarters. The position peaked at $3.04M in Q4 2019. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

  • Bessemer Group reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
  • Bessemer Group sold 95,500 Natus Medical Inc shares in Q3 2020, an estimated $2.08M.
  • Bessemer Group first reported a position in Natus Medical Inc in Q3 2016 and held it in 14 quarters.
  • Bessemer Group's Natus Medical Inc position peaked at $3.04M in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on Bessemer Group's 13F filing for Q3 2020, filed 12 Nov 2020.